These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 31571261)

  • 1. Stability and uniqueness of clonal immunoglobulin CDR3 sequences for MRD tracking in multiple myeloma.
    Rustad EH; Misund K; Bernard E; Coward E; Yellapantula VD; Hultcrantz M; Ho C; Kazandjian D; Korde N; Mailankody S; Keats JJ; Akhlaghi T; Viny AD; Mayman DJ; Carroll K; Patel M; Famulare CA; Op Bruinink DH; Hutt K; Jacobsen A; Huang Y; Miller JE; Maura F; Papaemmanuil E; Waage A; Arcila ME; Landgren O
    Am J Hematol; 2019 Dec; 94(12):1364-1373. PubMed ID: 31571261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloma VL and VH gene sequences reveal a complementary imprint of antigen selection in tumor cells.
    Sahota SS; Leo R; Hamblin TJ; Stevenson FK
    Blood; 1997 Jan; 89(1):219-26. PubMed ID: 8978295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating clonal lymphocytes in myeloma determined by mRNA in situ hybridization.
    Joshua DE; Brown RD; Luo XF; Gibson J
    Blood; 1996 Aug; 88(3):1125. PubMed ID: 8704226
    [No Abstract]   [Full Text] [Related]  

  • 4. A high frequency of circulating B cells share clonotypic Ig heavy-chain VDJ rearrangements with autologous bone marrow plasma cells in multiple myeloma, as measured by single-cell and in situ reverse transcriptase-polymerase chain reaction.
    Szczepek AJ; Seeberger K; Wizniak J; Mant MJ; Belch AR; Pilarski LM
    Blood; 1998 Oct; 92(8):2844-55. PubMed ID: 9763569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma.
    Jiang Y; Nie K; Redmond D; Melnick AM; Tam W; Elemento O
    J Vis Exp; 2015 Dec; (106):e53215. PubMed ID: 26780364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukemic B cells clonally identical to myeloma plasma cells are myelomagenic in NOD/SCID mice.
    Pilarski LM; Seeberger K; Coupland RW; Eshpeter A; Keats JJ; Taylor BJ; Belch AR
    Exp Hematol; 2002 Mar; 30(3):221-8. PubMed ID: 11882359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells.
    Hashimoto S; Dono M; Wakai M; Allen SL; Lichtman SM; Schulman P; Vinciguerra VP; Ferrarini M; Silver J; Chiorazzi N
    J Exp Med; 1995 Apr; 181(4):1507-17. PubMed ID: 7535340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the clonal hierarchy in light-chain multiple myeloma: implications against the myeloma stem cell hypothesis.
    Pfeifer S; Perez-Andres M; Ludwig H; Sahota SS; Zojer N
    Leukemia; 2011 Jul; 25(7):1213-6. PubMed ID: 21494259
    [No Abstract]   [Full Text] [Related]  

  • 9. Real-Time polymerase chain reaction of immunoglobulin rearrangements for quantitative evaluation of minimal residual disease in multiple myeloma.
    Ladetto M; Donovan JW; Harig S; Trojan A; Poor C; Schlossnan R; Anderson KC; Gribben JG
    Biol Blood Marrow Transplant; 2000; 6(3):241-53. PubMed ID: 10871149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A common clonal origin of nodal marginal zone B-cell lymphoma and plasma cell myeloma demonstrating different immunophenotypes: a case report of composite lymphoma.
    Saito H; Oka K; Nakamura N; Nagayama R; Hakozaki H; Mori N
    Diagn Mol Pathol; 2004 Jun; 13(2):75-80. PubMed ID: 15167008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative polymerase chain reaction analysis with allele-specific oligonucleotide primers for individual IgH VDJ regions to evaluate tumor burden in myeloma patients.
    Sata H; Shibayama H; Maeda I; Habuchi Y; Nakatani E; Fukushima K; Fujita J; Ezoe S; Tadokoro S; Maeda T; Mizuki M; Kosugi S; Nakagawa M; Ueda S; Iida M; Tokumine Y; Azenishi Y; Mitsui H; Oritani K; Kanakura Y
    Exp Hematol; 2015 May; 43(5):374-381.e2. PubMed ID: 25591497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variation.
    Bakkus MH; Heirman C; Van Riet I; Van Camp B; Thielemans K
    Blood; 1992 Nov; 80(9):2326-35. PubMed ID: 1421403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of a novel B cell clonality analysis using single-strand conformation polymorphism of immunoglobulin light chain messenger signals.
    Shiokawa S; Nishimura J; Ohshima K; Uike N; Yamamoto K
    Am J Pathol; 1998 Nov; 153(5):1393-400. PubMed ID: 9811330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline identification of clonal V(D)J sequences for DNA-based minimal residual disease detection in multiple myeloma.
    Rustad EH; Hultcrantz M; Yellapantula VD; Akhlaghi T; Ho C; Arcila ME; Roshal M; Patel A; Chen D; Devlin SM; Jacobsen A; Huang Y; Miller JE; Papaemmanuil E; Landgren O
    PLoS One; 2019; 14(3):e0211600. PubMed ID: 30901326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive assessment of potential multiple myeloma immunoglobulin heavy chain V-D-J intraclonal variation using massively parallel pyrosequencing.
    Tschumper RC; Asmann YW; Hossain A; Huddleston PM; Wu X; Dispenzieri A; Eckloff BW; Jelinek DF
    Oncotarget; 2012 Apr; 3(4):502-13. PubMed ID: 22522905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep sequencing reveals myeloma cells in peripheral blood in majority of multiple myeloma patients.
    Vij R; Mazumder A; Klinger M; O'Dea D; Paasch J; Martin T; Weng L; Park J; Fiala M; Faham M; Wolf J
    Clin Lymphoma Myeloma Leuk; 2014 Apr; 14(2):131-139.e1. PubMed ID: 24629890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of immunoglobulin genes in multiple myeloma.
    Kosmas C; Stamatopoulos K; Stavroyianni N; Belessi C; Viniou N; Yataganas X
    Leuk Lymphoma; 1999 Apr; 33(3-4):253-65. PubMed ID: 10221505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple myeloma: new evidence and insights from the immunoglobulin heavy chain gene and phenotypes.
    Takishita M; Kosaka M
    Leuk Lymphoma; 1995 Nov; 19(5-6):395-400. PubMed ID: 8590838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analytical evaluation of the clonoSEQ Assay for establishing measurable (minimal) residual disease in acute lymphoblastic leukemia, chronic lymphocytic leukemia, and multiple myeloma.
    Ching T; Duncan ME; Newman-Eerkes T; McWhorter MME; Tracy JM; Steen MS; Brown RP; Venkatasubbarao S; Akers NK; Vignali M; Moorhead ME; Watson D; Emerson RO; Mann TP; Cimler BM; Swatkowski PL; Kirsch IR; Sang C; Robins HS; Howie B; Sherwood A
    BMC Cancer; 2020 Jun; 20(1):612. PubMed ID: 32605647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent occurrence of highly expanded but unrelated B-cell clones in patients with multiple myeloma.
    Kriangkum J; Motz SN; Debes Marun CS; Lafarge ST; Gibson SB; Venner CP; Johnston JB; Belch AR; Pilarski LM
    PLoS One; 2013; 8(5):e64927. PubMed ID: 23724106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.